Is insulin resistance a predictor for complete response in breast cancer patients who underwent neoadjuvant treatment?

PURPOSE: Neoadjuvant chemotherapy is the standard front-line treatment modality in locally advanced breast cancer. Achieving pathological complete response (pCR) is a significant prognostic factor for prolonged disease-free and overall survival. Insulin resistance is defined as a pathological condit...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:World J Surg Oncol
Main Authors: Alan, Ozkan, Akin Telli, Tugba, Aktas, Bilge, Koca, Sinan, Ökten, Ilker Nihat, Hasanov, Rahib, Basoglu, Tugba, Arikan, Rukiye, Demircan, Nazim Can, Ercelep, Ozlem, Kaya, Serap, Ugurlu, Mustafa Umit, Kaya, Handan, Akgul Babacan, Nalan, Dane, Faysal, Yumuk, Perran Fulden
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2020
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7488234/
https://ncbi.nlm.nih.gov/pubmed/32907593
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12957-020-02019-y
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados